1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Autotransfusion Devices Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Autotransfusion Devices Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Autotransfusion Devices Market Regional Analysis
6.2 North America Autotransfusion Devices Market Revenue 2019-2028 (US$ Million)
6.3 North America Autotransfusion Devices Market Forecast Analysis
7. North America Autotransfusion Devices Market Analysis – by Type
7.1 Products
- 7.1.1 Overview
- 7.1.2 Products: North America Autotransfusion Devices Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Accessories
- 7.2.1 Overview
- 7.2.2 Accessories: North America Autotransfusion Devices Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Autotransfusion Devices Market Analysis – by Application
8.1 Cardiac Surgeries
- 8.1.1 Overview
- 8.1.2 Cardiac Surgeries: North America Autotransfusion Devices Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Orthopedic Surgeries
- 8.2.1 Overview
- 8.2.2 Orthopedic Surgeries: North America Autotransfusion Devices Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Organ Transplantation
- 8.3.1 Overview
- 8.3.2 Organ Transplantation: North America Autotransfusion Devices Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Trauma Procedures
- 8.4.1 Overview
- 8.4.2 Trauma Procedures: North America Autotransfusion Devices Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Autotransfusion Devices Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Autotransfusion Devices Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Specialty Clinics
- 9.2.1 Overview
- 9.2.2 Specialty Clinics: North America Autotransfusion Devices Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Ambulatory Surgery Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgery Centers : North America Autotransfusion Devices Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. North America Autotransfusion Devices Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Autotransfusion Devices Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 North America Autotransfusion Devices Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 US: North America Autotransfusion Devices Market Breakdown, by Type
- 10.2.1.1.2 US: North America Autotransfusion Devices Market Breakdown, by Application
- 10.2.1.1.3 US: North America Autotransfusion Devices Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Canada: North America Autotransfusion Devices Market Breakdown, by Type
- 10.2.1.2.2 Canada: North America Autotransfusion Devices Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Autotransfusion Devices Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Mexico : North America Autotransfusion Devices Market Breakdown, by Type
- 10.2.1.3.2 Mexico : North America Autotransfusion Devices Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America Autotransfusion Devices Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 BD
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Braile Biomedica
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Fresenius SE & Co. KGaA
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Haemonetics Corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 LivaNova PLC
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Medtronic
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Redax S.p.A.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 SARSTEDT AG and Co. KG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Teleflex Incorporated
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Zimmer Biomet
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations